MGIM
STIM icon

M&G Investment Management’s Neuronetics STIM Stock Holding History

M&G Investment Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-236,683
Closed -$1.66K – 717
2021
Q3 		$1.66K Buy
236,683
+65,751
+38% +$631K ﹤0.01% 540
2021
Q2 		$2.73K Buy
+170,932
New +$2.36M 0.01% 480

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

M&G Investment Management's STIM Position: Q4 2021 in Review

M&G Investment Management sold out of Neuronetics (STIM) in Q4 2021, closing a stake of 236,683 shares — an estimated $1.66K sold.

M&G Investment Management first reported a position in STIM in Q2 2021 and held it in 2 quarters. The position peaked at $2.73K in Q2 2021. 80 funds tracked by Wall St. Rank hold STIM as of Q4 2021.

  • M&G Investment Management reported no remaining Neuronetics position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 236,683 Neuronetics shares in Q4 2021, an estimated $1.66K.
  • M&G Investment Management first reported a position in Neuronetics in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Neuronetics position peaked at $2.73K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Neuronetics as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.